A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction

Mise à jour : Il y a 4 ans
Référence : NCT01273493

Femme et Homme

Extrait

The purpose of this study is to characterize the pharmacokinetics (blood levels) of trabectedin after administration to patients with advanced malignancies and hepatic (liver) dysfunction.


Critère d'inclusion

  • Neoplasm Metastases ,Hepatic Insufficiency


Liens